FEIBA(R) in treatment of acute bleeding episodes in patients
with haemophilia A and factor VIII inhibitors: a retrospective
survey in regional haemophilia centre

J 2009

FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre

SMEJKAL, Petr, Petr BRABEC, Miloslava MATÝŠKOVÁ, Alena BULIKOVÁ, Marie ŠLECHTOVÁ et. al.

Základní údaje

Originální název

FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre

Název česky

FEIBA(R) v léčbě akutního krvácení u pacientů s hemofilií A a inhibitorem faktoru VIII: retrospektivní studie regionálního centra

Autoři

SMEJKAL, Petr (203 Česká republika, garant), Petr BRABEC (203 Česká republika), Miloslava MATÝŠKOVÁ (203 Česká republika), Alena BULIKOVÁ (203 Česká republika), Marie ŠLECHTOVÁ (203 Česká republika), Jarmila KISSOVÁ (203 Česká republika), Gabriela CHLUPOVÁ (203 Česká republika), Jan MUŽÍK (203 Česká republika) a Miroslav PENKA (203 Česká republika)

Vydání

Haemophilia, 2009, 1351-8216

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.505

Kód RIV

RIV/00216224:14110/09:00036074

Organizační jednotka

Lékařská fakulta

UT WoS

000265409600013

Klíčová slova anglicky

haemophilia; bleeding; FEIBA

Štítky

bleeding, FEIBA, haemophilia

Změněno: 1. 4. 2010 14:42, RNDr. Jan Mužík, Ph.D.

Anotace

ORIG CZ

V originále

FEIBA(R) is used to achieve haemostasis in haemophiliacs with inhibitor. The aim of this study was to evaluate efficacy and consumption of the product in treatment of haemorrhages in haemophiliacs with factor VIII inhibitor, and determine factors that can influence the results of treatment. We used data from our haemophilia centre from years 2000-2008. Six haemophiliacs with factor VIII inhibitor were treated on demand with FEIBA(R) for 61 bleeding episodes (45 haemarthroses, six muscle bleeds, six other sites bleeds and four multiple sites bleeds).

Česky

Citovat

SMEJKAL, Petr, Petr BRABEC, Miloslava MATÝŠKOVÁ, Alena BULIKOVÁ, Marie ŠLECHTOVÁ, Jarmila KISSOVÁ, Gabriela CHLUPOVÁ, Jan MUŽÍK a Miroslav PENKA. FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre. Haemophilia. 2009, roč. 15, č. 3, s. 743-751. ISSN 1351-8216.

@article{838792,
   author = {Smejkal, Petr and Brabec, Petr and Matýšková, Miloslava and Buliková, Alena and Šlechtová, Marie and Kissová, Jarmila and Chlupová, Gabriela and Mužík, Jan and Penka, Miroslav},
   article_number = {3},
   keywords = {haemophilia; bleeding; FEIBA},
   language = {eng},
   issn = {1351-8216},
   journal = {Haemophilia},
   title = {FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre},
   volume = {15},
   year = {2009}
}

TY  - JOUR
ID  - 838792
AU  - Smejkal, Petr - Brabec, Petr - Matýšková, Miloslava - Buliková, Alena - Šlechtová, Marie - Kissová, Jarmila - Chlupová, Gabriela - Mužík, Jan - Penka, Miroslav
PY  - 2009
TI  - FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre
JF  - Haemophilia
VL  - 15
IS  - 3
SP  - 743-751
EP  - 743-751
SN  - 13518216
KW  - haemophilia
KW  - bleeding
KW  - FEIBA
N2  - FEIBA(R) is used to achieve haemostasis in haemophiliacs with inhibitor. The aim of this study was to evaluate efficacy and consumption of the product in treatment of haemorrhages in haemophiliacs with factor VIII inhibitor, and determine factors that can influence the results of treatment. We used data from our haemophilia centre from years 2000-2008. Six haemophiliacs with factor VIII inhibitor were treated on demand with FEIBA(R) for 61 bleeding episodes (45 haemarthroses, six muscle bleeds, six other sites bleeds and four multiple sites bleeds).
ER  -

SMEJKAL, Petr, Petr BRABEC, Miloslava MATÝŠKOVÁ, Alena BULIKOVÁ, Marie ŠLECHTOVÁ, Jarmila KISSOVÁ, Gabriela CHLUPOVÁ, Jan MUŽÍK a Miroslav PENKA. FEIBA(R) in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre. \textit{Haemophilia}. 2009, roč.~15, č.~3, s.~743-751. ISSN~1351-8216.

Podrobný výpis o publikaci